LobbyingClaritev lobbying by quarter
Claritev's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q2 2024; the issues it reports most are Health Issues and Labor Issues/Antitrust/Workplace.
Claritev
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $200K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $40K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $80K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$346.7K · 9 reports
- Labor, antitrust and workplace$146.7K · 6 reports
- Medicare and Medicaid$146.7K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $640K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SAMANTHA MCLEAN | Senior LA, Senator Cruz (2018-2023); LA, Senator Cruz (2016-2018); Leg Aid, Senator Cruz (2013-2016); Assistant to the CoS and LD, Senator Cruz (2013-2013); SA, Senator DeMint (2012-2012). | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 05/22for Q2 | Forbes-Tate | $40K |
| 04/17for Q1 | Forbes-Tate | $80K |
| 01/18for Q4 2025 | Forbes-Tate | $80K |
| 25/10/19for Q3 2025 | Forbes-Tate | $80K |
| 25/07/18for Q2 2025 | Forbes-Tate | $80K |
| 25/04/18for Q1 2025 | Forbes-Tate | $80K |
| 25/01/18for Q4 2024 | Forbes-Tate | $80K |
| 24/10/17for Q3 2024 | Forbes-Tate | $80K |
| 24/07/17for Q2 2024 | Forbes-Tate | $40K |
| 24/07/14for Q2 2024 | Forbes-Tate | $50K |
| 24/06/27for Q2 2024 | Forbes-Tate | Under $5,000 |